1Older RA, Synder B, Krupski TL, et al. Radioactive implant migration in patients treated for localized prostate cancer with interstitial brachytherapy [ J ]. J Urol,2001, 165(5) :1 590-1 592.
2Lee W, Daly BD, DiPetrillo TA, et al. Limited resection for nonsmall cell lung cancer: observed local control with implantation of Ⅰ- 125 brachytherapy seeds [ J ]. Ann Thorac Surg, 2003,75 ( 1 ) : 237 - 243.
3Gaspar LE, Zamorano M,Shamsa F, et al. Permanent 125 Iodine implants for recurrent malignant gliomas[ J]. Int J Radiation Ontology Bio Phys, 1999,43(5) :977-982.
4Haligan JB, Stelzer KJ, Rostomily RC, et al. Operation and permanent low activity ^125 I brachytherapy for recurrent high-grade astrocytomas[J]. Int J Radiation Oncology Bio Phys, 1996,35(3) : 341-347.
5Langley SE, Laing RW. Iodine seed prostate brachytherapy: an alternative first-line choice for early prostate cancer[J]. Prostate Cancer Prostatic Dis,2004,7(3):201-207.
6Keyes M, Pickles T, Agranovich A, et al. 125Ⅰ reimplantation in patients with poor initial dosimetry after prostate brachytherapy[J]. Int J Radiat Oncol Biol Phys, 2004, 60(1): 40-50.
7Zelefsky MJ, Hollister T, Raben A, et al. Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys,2000,47:1261-1266.
8Willins J, Wallner K. CT-based dosimetry for transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys,1997,39:347-353.
9Molloy JA, Williams MB. Treatment planning considerations and quality assurance for CT-guided transischiorectal implantation of the prostate. Med Phys,1999,26:1943-1951.
10Martinez-Monge R, Nag S, Nieroda CA, et al. Iodine-125 brachytherapy in the treatment of colorectal adenocarcinoma metastatic to the liver. Cancer,1999,85:1218-1225.
